Literature DB >> 12649076

Caveolae-associated proteins in cardiomyocytes: caveolin-2 expression and interactions with caveolin-3.

Vitalyi O Rybin1, Peter W Grabham, Hasnae Elouardighi, Susan F Steinberg.   

Abstract

Caveolin-3 the muscle-specific caveolin isoform, acts like the more ubiquitously expressed caveolin-1 to sculpt caveolae, specialized membrane microdomains that serve as platforms to organize signal transduction pathways. Caveolin-2 is a structurally related isoform that alone does not drive caveolae biogenesis; rather, caveolin-2 cooperates with caveolin-1 to form caveolae in nonmuscle cells. Although caveolin-2 might be expected to interact in an fashion analogous to that of caveolin-3, it generally has not been detected in cardiomyocytes. This study shows that caveolin-2 and caveolin-3 are detected at low levels in ventricular myocardium and increase dramatically with age or when neonatal cardiomyocytes are placed in culture. In contrast, flotillins (caveolin functional homologs) are expressed at relatively constant levels in these preparations. In neonatal cardiac cultures, caveolin-2 and -3 expression is not influenced by thyroid hormone (a postnatal regulator of other cardiac gene products). The further evidence that caveolin-2 coimmunoprecipitates with caveolin-3 and floats with caveolin-3 by isopycnic centrifugation in cardiomyocyte cultures suggests that caveolin-2 may play a role in caveolae biogenesis and influence cardiac muscle physiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649076     DOI: 10.1152/ajpheart.00946.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  21 in total

Review 1.  The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.

Authors:  Rennolds S Ostrom; Paul A Insel
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

2.  Effect of cholesterol depletion on exocytosis of alveolar type II cells.

Authors:  Narendranath Reddy Chintagari; Nili Jin; Pengcheng Wang; Telugu Akula Narasaraju; Jiwang Chen; Lin Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-26       Impact factor: 6.914

Review 3.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 4.  Caveolins in cardioprotection - translatability and mechanisms.

Authors:  Jan M Schilling; David M Roth; Hemal H Patel
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

5.  Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention.

Authors:  Jianing Meng; Tao Zhang; Vivek Agrahari; Miezan J Ezoulin; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2014-01-10       Impact factor: 5.307

6.  Modulation of Ca²+ activity in cardiomyocytes through caveolae-Gαq interactions.

Authors:  Yuanjian Guo; Urszula Golebiewska; Suzanne Scarlata
Journal:  Biophys J       Date:  2011-04-06       Impact factor: 4.033

7.  Involvement of caveolin in low K+-induced endocytic degradation of cell-surface human ether-a-go-go-related gene (hERG) channels.

Authors:  Hamid Massaeli; Tao Sun; Xian Li; Heidi Shallow; Jimmy Wu; Jianmin Xu; Wentao Li; Christian Hanson; Jun Guo; Shetuan Zhang
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

Review 8.  Caveolae, ion channels and cardiac arrhythmias.

Authors:  Ravi C Balijepalli; Timothy J Kamp
Journal:  Prog Biophys Mol Biol       Date:  2009-01-30       Impact factor: 3.667

9.  Increased caveolae density and caveolin-1 expression accompany impaired NO-mediated vasorelaxation in diet-induced obesity.

Authors:  T Hilton Grayson; Preet S Chadha; Paul P Bertrand; Hui Chen; Margaret J Morris; Sevvandi Senadheera; Timothy V Murphy; Shaun L Sandow
Journal:  Histochem Cell Biol       Date:  2012-09-25       Impact factor: 4.304

Review 10.  Channelopathies from mutations in the cardiac sodium channel protein complex.

Authors:  Graham S Adsit; Ravi Vaidyanathan; Carla M Galler; John W Kyle; Jonathan C Makielski
Journal:  J Mol Cell Cardiol       Date:  2013-04-01       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.